News | April 17, 2026
NIFTY Pharma shows stable trend amid cautious market sentiment
Muted movement reflects consolidation phase as investors await earnings triggers
Muted movement reflects consolidation phase as investors await earnings triggers
Dr Desai argued that the sector is undergoing a structural acceleration in how quickly science turns into treatments
In his new role, Karthik will lead human capital strategy and HR operations across these regions
CDSCO-approved therapy enters India’s fast-growing post-patent GLP-1 market with fully integrated API, formulation and pen manufacturing
At India Pharma 2026, Dr Bahl calls for experimentation over imitation as funding rises and translational ecosystem reforms gather pace
Benefits were consistent across all key subgroups, including patients previously treated with covalent BTK inhibitors
The campaign builds on the three-year partnership unveiled earlier this season
This event will bring together global stakeholders to explore India’s growing capabilities in pharma and biopharma innovation, research, and manufacturing
MoU aims to strengthen academia-industry collaboration in healthcare research and innovation
The two-day conference and exhibition features discussions on policy frameworks, AI-led drug discovery, next-generation technologies, and global competitiveness
Subscribe To Our Newsletter & Stay Updated
